Skip to content

Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide

C44H60F2N4O9S — CID 158926650

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide
SMILESC.CC[C@@H]1[C@@H]2CN(C(=O)[C@H](C(C)(C)C)CC(=O)O[C@@H]3C[C@H]3CCCC3CC3c3nc4ccc(OC)cc4nc3O2)[C@@H]1C(=O)C[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C(F)F
InChIInChI=1S/C43H56F2N4O9S.CH4/c1-7-25-33-21-49(36(25)31(50)20-43(19-28(43)37(44)45)40(53)48-59(54,55)42(5)13-14-42)39(52)27(41(2,3)4)18-34(51)57-32-16-23(32)10-8-9-22-15-26(22)35-38(58-33)47-30-17-24(56-6)11-12-29(30)46-35;/h11-12,17,22-23,25-28,32-33,36-37H,7-10,13-16,18-21H2,1-6H3,(H,48,53);1H4/t22?,23-,25-,26?,27-,28+,32-,33+,36+,43-;/m1./s1
InChIKeyJINKWLJFQPRXFU-ZBSLQQCKSA-N
MW859.05 g/mol
LogP6.76
Rot. Bonds9

About Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide

Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide (PubChem CID 158926650) has the molecular formula C44H60F2N4O9S and a molecular weight of 859.05 g/mol. Its IUPAC name is methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide.

Molecular Properties

Compound NameMethane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide
PubChem CID158926650
Molecular FormulaC44H60F2N4O9S
Molecular Weight859.05 g/mol
Exact Mass858.40
IUPAC Namemethane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide
SMILESC.CC[C@@H]1[C@@H]2CN(C(=O)[C@H](C(C)(C)C)CC(=O)O[C@@H]3C[C@H]3CCCC3CC3c3nc4ccc(OC)cc4nc3O2)[C@@H]1C(=O)C[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C(F)F
InChIInChI=1S/C43H56F2N4O9S.CH4/c1-7-25-33-21-49(36(25)31(50)20-43(19-28(43)37(44)45)40(53)48-59(54,55)42(5)13-14-42)39(52)27(41(2,3)4)18-34(51)57-32-16-23(32)10-8-9-22-15-26(22)35-38(58-33)47-30-17-24(56-6)11-12-29(30)46-35;/h11-12,17,22-23,25-28,32-33,36-37H,7-10,13-16,18-21H2,1-6H3,(H,48,53);1H4/t22?,23-,25-,26?,27-,28+,32-,33+,36+,43-;/m1./s1
InChIKeyJINKWLJFQPRXFU-ZBSLQQCKSA-N
XLogP6.76
TPSA171.16 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds9
Heavy Atoms60
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500859.05
LogP ≤ 56.76
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Analyze Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide?
The IUPAC name of Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide (CID 158926650) is methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide.
What is the SMILES notation for Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide?
The canonical SMILES for Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide is C.CC[C@@H]1[C@@H]2CN(C(=O)[C@H](C(C)(C)C)CC(=O)O[C@@H]3C[C@H]3CCCC3CC3c3nc4ccc(OC)cc4nc3O2)[C@@H]1C(=O)C[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C(F)F.
What is the InChIKey of Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide?
The InChIKey is JINKWLJFQPRXFU-ZBSLQQCKSA-N. The full InChI is InChI=1S/C43H56F2N4O9S.CH4/c1-7-25-33-21-49(36(25)31(50)20-43(19-28(43)37(44)45)40(53)48-59(54,55)42(5)13-14-42)39(52)27(41(2,3)4)18-34(51)57-32-16-23(32)10-8-9-22-15-26(22)35-38(58-33)47-30-17-24(56-6)11-12-29(30)46-35;/h11-12,17,22-23,25-28,32-33,36-37H,7-10,13-16,18-21H2,1-6H3,(H,48,53);1H4/t22?,23-,25-,26?,27-,28+,32-,33+,36+,43-;/m1./s1.
What are the key properties of Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide?
Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide has a molecular weight of 859.05 g/mol, XLogP of 6.76, 9 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for Methane;trans-(1R,2R)-1-[2-[(1R,19R,21R,25S,28S,29S)-25-tert-butyl-29-ethyl-7-methoxy-23,26-dioxo-2,22-dioxa-4,11,27-triazahexacyclo[25.2.1.03,12.05,10.013,15.019,21]triaconta-3,5(10),6,8,11-pentaen-28-yl]-2-oxoethyl]-2-(difluoromethyl)-N-(1-methylcyclopropyl)sulfonylcyclopropane-1-carboxamide is sourced from PubChem (CID 158926650), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.